These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4459861)

  • 21. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.
    Gordon MF; Abrams RI; Rubin DB; Barr WB; Correa DD
    Mov Disord; 1995 Mar; 10(2):220-2. PubMed ID: 7753066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bismuth encephalopathy].
    Hazemann P; Rebelo F; Landau J
    Rev Electroencephalogr Neurophysiol Clin; 1975; 5(3):291-4. PubMed ID: 1230924
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myoclonic encephalopathy caused by bismuth].
    Gómez Jiménez J; Alvarez J; Boada Rovira M; Codina-Puiggros A
    Rev Clin Esp; 1989 Mar; 184(4):212. PubMed ID: 2740555
    [No Abstract]   [Full Text] [Related]  

  • 24. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and electroencephalographic aspects of encephalopathy caused by insoluble bismuth salts. Apropos of 9 cases].
    Mabin D; Bedou G; Tuset MC
    Sem Hop Ther; 1976 Feb; 52(2):109-16. PubMed ID: 982067
    [No Abstract]   [Full Text] [Related]  

  • 26. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 27. [Letter: Encephalopathies during treatment with bismuth or the mishaps of"conjugated" bismuth therapy].
    Raverdy P; Smagghe A; Marie JP; Prinseau J
    Nouv Presse Med; 1975 Apr; 4(14):1050. PubMed ID: 805409
    [No Abstract]   [Full Text] [Related]  

  • 28. [Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment].
    Nogué S; Mas A; Parés A; Nadal P; Bertrán A; Torra M; Bachs M; Blesa R
    Med Clin (Barc); 1985 Apr; 84(13):530-2. PubMed ID: 3999823
    [No Abstract]   [Full Text] [Related]  

  • 29. [Encephalopathy caused by bismuth has not disappeared...].
    Vidailhet M; Le TH; Wechsler B; Godeau P
    Presse Med; 1987 Jun; 16(21):1054. PubMed ID: 2955328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bismuth encephalopathy. A propos of 2 cases].
    Loutre JC; Viguié R; Kunstler E; Nehlil J
    Rev Neurol (Paris); 1975 Dec; 131(12):883-6. PubMed ID: 1232663
    [No Abstract]   [Full Text] [Related]  

  • 31. [Polygraphic study of bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Tassinari CA; Terzano G; Picornell I
    Rev Electroencephalogr Neurophysiol Clin; 1975; 5(3):295-302. PubMed ID: 1230925
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myoclonic encephalopathy due to bismuth subnitrate. A recent case].
    Goas JY; Borsotti JP; Missoum A; Allain P; Chaleil D
    Nouv Presse Med; 1981 Dec; 10(47):3855. PubMed ID: 7329800
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myoclonic encephalopathy due to bismuth poisoning].
    Besle A; Bussel B; Chapelle JG; Scherrer P
    Ann Med Psychol (Paris); 1975 Apr; 1(4):493-8. PubMed ID: 1233892
    [No Abstract]   [Full Text] [Related]  

  • 34. Myoclonic encephalopathy caused by chronic bismuth abuse.
    Teepker M; Hamer HM; Knake S; Bandmann O; Oertel WH; Rosenow F
    Epileptic Disord; 2002 Dec; 4(4):229-33. PubMed ID: 12600808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Letter: Encephalopathies caused by bismuth].
    Barbizet J; Degos JD; Bouchareine A
    Nouv Presse Med; 1975 Apr; 4(17):1290-1. PubMed ID: 1153289
    [No Abstract]   [Full Text] [Related]  

  • 36. [Encephalopathy after oral ingestion of bismuth salt over a short time period (10 days)].
    Davous P; Bouche P; Derouesne C; Castaigne P
    Nouv Presse Med; 1977 Oct; 6(36):3336. PubMed ID: 593865
    [No Abstract]   [Full Text] [Related]  

  • 37. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine].
    Boiteau HL; Cler JM; Mathé JF; Delobel R; Fève J
    Eur J Toxicol Environ Hyg; 1976; 9(4):233-9. PubMed ID: 976332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bismuth associated myoclonic encephalopathy: is a prevention possible? (author's transl)].
    Grandjean EM
    Schweiz Rundsch Med Prax; 1977 Jan; 66(3):59-61. PubMed ID: 834718
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iatrogenic myoclonic encephalopathies caused by bismuth salts].
    Loiseau P; Henry P; Jallon P; Legroux M
    J Neurol Sci; 1976 Feb; 27(2):133-43. PubMed ID: 1249582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humeral head necrosis during bismuth encephalopathy (author's transl)].
    Mabille JP; Gaudet M; Charpin JF
    Sem Hop; 1981 Feb 18-25; 57(7-8):389-91. PubMed ID: 6261377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.